Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB) Return on Capital Employed (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Return on Capital Employed for 3 consecutive years, with 0.41% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 78.0% to 0.41% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.41%, a 78.0% increase, with the full-year FY2025 number at 0.44%, up 69.0% from a year prior.
  • Return on Capital Employed was 0.41% for Q4 2025 at Nuvation Bio, up from 0.42% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.16% in Q1 2024 to a low of 1.36% in Q1 2025.
  • A 3-year average of 0.69% and a median of 0.45% in 2025 define the central range for Return on Capital Employed.
  • Biggest YoY gain for Return on Capital Employed was 78bps in 2025; the steepest drop was -121bps in 2025.
  • Nuvation Bio's Return on Capital Employed stood at 0.16% in 2023, then plummeted by -630bps to 1.19% in 2024, then soared by 65bps to 0.41% in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Return on Capital Employed are 0.41% (Q4 2025), 0.42% (Q3 2025), and 0.45% (Q2 2025).